CLINICAL SUPPLY MANAGEMENT ARTICLES
Sourcing Through The Tariff Mess: What 2026 Actually Means For Clinical Supply
US tariff changes are reshaping clinical supply sourcing. Learn how pharmaceutical duties, country-of-origin documentation and temporary import provisions affect trial materials.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Master complex cell therapy logistics with coordinated depots, purpose-built labeling, and temperature-controlled solutions that protect product integrity.
-
Tariffs and geopolitical disruptions are reshaping supply chains. Companies must act now to strengthen continuity planning, evaluate tariff recovery opportunities, and build more resilient logistics strategies for the future.
-
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
Emerging biotech sponsors need packaging and labeling that scale from Phase 1 to launch without slowing trials. Label translation, cold chain, and tamper security are central to protecting timelines.
-
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.